Increased vancomycin minimum inhibitory concentration among Staphylococcus aureus isolates in Malaysia

scientific article published on August 19, 2010

Increased vancomycin minimum inhibitory concentration among Staphylococcus aureus isolates in Malaysia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1099/JMM.0.022079-0
P953full work available at URLhttp://jmm.sgmjournals.org/cgi/content/abstract/59/12/1530
https://doi.org/10.1099/jmm.0.022079-0
https://www.microbiologyresearch.org/content/journal/jmm/10.1099/jmm.0.022079-0?crawler=true
P698PubMed publication ID20724515
P5875ResearchGate publication ID45720869

P2093author name stringNorazah Ahmad
Salbiah Nawi
Nurahan Maning
Ganeswrie Rajasekaran
Azura Husin
Mohamad Nazri Aziz
Nor Iza Abdul Rahman
P2860cites workVancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method usedQ43202070
Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong KongQ43229615
High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicityQ45302930
Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infectionsQ46431265
Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremiaQ46826194
Microbiological effects of prior vancomycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemia.Q46879391
Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus: a 20 year study in a large French teaching hospital, 1983-2002.Q46892794
Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05Q80595494
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremiaQ34783668
Staphylococcus aureus with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic MethodsQ35541702
Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycinQ36870858
Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptidesQ39465279
Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year periodQ41066970
Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureusQ41873909
Vancomycin treatment failure in a vancomycin susceptible methicillin-resistant Staphylococcus aureus (MRSA) infected patientQ43199496
P433issuePt 12
P407language of work or nameEnglishQ1860
P921main subjectMalaysiaQ833
Staphylococcus aureusQ188121
vancomycinQ424027
bacterial drug resistanceQ64924127
P304page(s)1530-1532
P577publication date2010-08-19
P1433published inJournal of Medical MicrobiologyQ15708716
P1476titleIncreased vancomycin minimum inhibitory concentration among Staphylococcus aureus isolates in Malaysia
P478volume59

Reverse relations

Q33560625Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infection and the molecular characteristics of MRSA bacteraemia over a two-year period in a tertiary teaching hospital in Malaysiacites workP2860

Search more.